RENATA PEYREAU: Open Payments
NPI 1316188758 · WHITEHOUSE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 49 payments from 18 companies in 2025. Trend: 2023 $692 · 2024 $853 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $236 |
| Novo Nordisk Inc | 3 | $156 |
| GlaxoSmithKline, LLC. | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 6 | $98 |
| Abbott Laboratories | 1 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $43 |
| Corcept Therapeutics | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
Products named: REPATHA, Wegovy, LEQVIO, FREESTYLE LIBRE 3, OTEZLA, Kerendia, VYEPTI, Korlym.
Industry payments across TX — which companies pay providers there.
